MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer.
Johnston S, Martin M, Di Leo A, Im SA, Awada A, Forrester T, Frenzel M, Hardebeck MC, Cox J, Barriga S, Toi M, Iwata H, Goetz MP.
Johnston S, et al. Among authors: awada a.
NPJ Breast Cancer. 2019 Jan 17;5:5. doi: 10.1038/s41523-018-0097-z. eCollection 2019.
NPJ Breast Cancer. 2019.
PMID: 30675515
Free PMC article.